Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Edwards Lifesciences Corp (EW)  
$30.21 0.41 (1.36%) as of 4:30 Tue 5/28


Download
   
Exchange: New York Stock Exchange
Security Type: Common
Shares Out: 623,250,000
Market Cap: 18.83(B)
Last Volume: 1,481,256 Avg Vol: 1,477,198
52 Week Range: $27.6017 - $30.88
Level I Sector: Health Care
Level II Sector: Health Services
Level III Sector: Medical Appliances & Equipment

Member Indexes:
    S&P COMPOSITE 1500     NYSE COMPOSITE
    S&P 400 MIDCAP

Rankings:
     
Insider 3 Months    : 5.8
Insider 6 Months    : 5.8
Insider 3/6 Months : 12
Guru Rank Number :  1033
Guru Rank Value     : -0.5
Guru Occurances    : 2

 

            6 Months   1 Year   2 Year  
 
Company Profile   Edwards Lifesciences is focused on technologies that treat structural heart disease and ill patients. The products and technologies provided by Co. are categorized into the several main areas, including: Transcatheter Aortic Valve Replacement, which is engaged in transcatheter heart valve replacement technologies designed for the minimally-invasive replacement of aortic heart valves; Transcatheter Mitral and Tricuspid Therapies, which is focused on the development of transcatheter heart valve repair and replacement technologies designed to treat mitral and tricuspid valve diseases; and Surgical Structural Heart, which is engaged in resilient surgical therapies.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 580 580 580 580
Total Buy Value $49,753 $49,753 $49,753 $49,753
Total People Bought 1 1 1 1
Total Buy Transactions 1 1 1 1
Total Shares Sold 194,064 429,561 765,460 1,359,951
Total Sell Value $17,268,041 $36,229,642 $62,356,910 $113,453,221
Total People Sold 5 11 11 13
Total Sell Transactions 16 33 65 113
End Date 2024-02-29 2023-11-28 2023-05-30 2022-05-30

   
Records found: 2897
  Page 3 of 116  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Chopra Daveen CVP, TMTT   •       •      –    2024-05-04 4 D $85.25 $197,865 D/D (2,321) 24,851     -
   Chopra Daveen CVP, TMTT   •       •      –    2024-05-04 4 OE $0.00 $0 D/D 4,713 27,172     -
   Ullem Scott B. CVP, Chief Financial Officer   •       •      –    2024-05-04 4 D $85.25 $377,743 D/D (4,431) 21,474     -
   Ullem Scott B. CVP, Chief Financial Officer   •       •      –    2024-05-04 4 OE $0.00 $0 D/D 7,465 25,905     -
   Bobo Donald E Jr CVP,Strategy/Corp Development   •       •      –    2024-05-04 4 D $85.25 $296,244 D/D (3,475) 41,669     -
   Bobo Donald E Jr CVP,Strategy/Corp Development   •       •      –    2024-05-04 4 OE $0.00 $0 D/D 5,855 45,144     -
   Lemercier Jean-Luc M CVP, EMEACLA and JAPAC   •       •      –    2024-05-04 4 OE $0.00 $0 D/D 4,157 177,969     -
   Sellers Robert W.a. SVP, Corporate Controller   •       •      –    2024-05-04 4 D $85.25 $10,230 D/D (120) 15,043     -
   Zovighian Bernard J CEO   •       •      –    2024-05-03 4 D $85.06 $44,827 D/D (527) 44,289     -
   Szyman Catherine M CVP, Critical Care   •       •      –    2024-05-03 4 D $85.06 $40,744 D/D (479) 43,222     -
   Lippis Daniel J. CVP, JAPAC   •       •      –    2024-05-03 4 D $85.06 $23,902 D/D (281) 17,207     -
   Wood Larry L Global President TAVR & Surg   •       •      –    2024-05-03 4 D $85.06 $33,599 D/D (395) 213,347     -
   Chopra Daveen CVP, TMTT   •       •      –    2024-05-03 4 D $85.06 $24,752 D/D (291) 22,459     -
   Ullem Scott B. CVP, Chief Financial Officer   •       •      –    2024-05-03 4 D $85.06 $53,928 D/D (634) 18,440     -
   Bobo Donald E Jr CVP,Strategy/Corp Development   •       •      –    2024-05-03 4 D $85.06 $40,744 D/D (479) 39,289     -
   Lemercier Jean-Luc M CVP, EMEACLA and JAPAC   •       •      –    2024-05-03 4 D $85.06 $3,147 D/D (37) 173,812     -
   Sellers Robert W.a. SVP, Corporate Controller   •       •      –    2024-05-03 4 D $85.06 $9,016 D/D (106) 15,163     -
   Mussallem Michael A Director   •       •      –    2024-05-02 4 AS $84.59 $2,487,966 D/D (29,350) 4,486 3%     
   Mussallem Michael A Director   •       •      –    2024-05-02 4 OE $36.75 $1,078,613 D/D 29,350 33,836     -
   Lemercier Jean-Luc M CVP, EMEACLA and JAPAC   •       •      –    2024-05-01 4 AS $84.11 $1,212,687 D/D (14,400) 173,849 3%     
   Lemercier Jean-Luc M CVP, EMEACLA and JAPAC   •       •      –    2024-05-01 4 OE $36.75 $529,200 D/D 14,400 188,249     -
   Ullem Scott B. CVP, Chief Financial Officer   •       •      –    2024-04-30 4 AS $85.74 $622,062 D/D (7,250) 19,074 3%     
   Ullem Scott B. CVP, Chief Financial Officer   •       •      –    2024-04-30 4 OE $36.75 $266,438 D/D 7,250 26,324     -
   Lippis Daniel J. CVP, JAPAC   •       •      –    2024-04-09 4 AS $92.34 $79,135 D/D (857) 17,488 1%     
   Lippis Daniel J. CVP, JAPAC   •       •      –    2024-04-09 4 OE $36.75 $31,495 D/D 857 18,345     -
  2897 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 3 of 116
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us